Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and S
about
Developing therapeutic approaches for metachromatic leukodystrophyBone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism miceGene therapy for metachromatic leukodystrophy.Microglia as a critical player in both developmental and late-life CNS pathologies.Progression of multiple behavioral deficits with various ages of onset in a murine model of Hurler syndrome.Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapyCell- and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidosesMucopolysaccharidosis VI.Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone.Systematic approach to the diagnosis of lysosomal storage disorders.Gaucher disease: pathological mechanisms and modern management.Angiokeratoma corporis diffusum in a Spanish patient with aspartylglucosaminuria.Combination therapies for lysosomal storage disease: is the whole greater than the sum of its parts?Lysosomal storage disease: gene therapy on both sides of the blood-brain barrier.Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses.Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines.Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry.Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice.Disease specific therapies in leukodystrophies and leukoencephalopathies.Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report.White matter dementia.Neuropsychological symptoms of juvenile-onset batten disease: experiences from 2 studiesDeterminants of health care use in a population-based leukodystrophy cohort.A Prospective Natural History Study of Mucopolysaccharidosis Type IIIA.Juvenile metachromatic leukodystrophy: understanding the disease and implications for nursing care.Novel candidate disease for gene therapy: metachromatic leukodystrophy.A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity.Emerging trends in transplantation of inherited metabolic diseases.Human CD34+ cells differentiate into microglia and express recombinant therapeutic proteinMethods for assessing neurodevelopment in lysosomal storage diseases and related disorders: a multidisciplinary perspective.In utero transplantation of monocytic cells in cats with alpha-mannosidosis.Enzyme therapy for the treatment of type 1 Gaucher disease: clinical outcomes and dose - response relationships.Lysosomal lipid storage diseases.Angiokeratoma: decision-making aid for the diagnosis of Fabry disease.Biotechnological and biomedical applications of mesenchymal stem cells as a therapeutic system.Emerging treatments for pediatric leukodystrophies.Implications of mesenchymal stem cells in regenerative medicine.Combination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem.Transplantation in inborn errors of metabolism: current considerations and future perspectives.alpha-L-iduronidase therapy for mucopolysaccharidosis type I.
P2860
Q28297086-59A26B2C-CBBC-460C-8699-9BFDCE53B61FQ30009268-33FD7A6C-D19B-4673-B753-319E3840BBACQ30357745-28FA83DC-624F-4D90-A4E3-E0599E1C6FEEQ30411278-31B90975-0387-497C-BE9B-9BAC85A5E1A7Q30491775-19F25BE9-FD1D-4B54-BCCC-76ECB8E51CFAQ30541880-CB47C18A-7E7B-4CE8-AB29-BFC8F2E98278Q33692991-37BADD03-1412-4757-90B9-1B3D2542CC02Q33863356-06A8B2BB-1E80-41C4-8D38-C3CBB0F2DFECQ34066339-D1608BD6-63A3-4870-975E-1A66823D08E5Q34366699-BD260B75-AFF0-4A0A-8E76-F837A70CA966Q34556549-E0BC6EB6-1673-4ABB-BB97-BC48CC0A2B9CQ34941297-FB78B263-F9DF-4F61-AB64-FD3965CC3400Q34982831-3599FE4B-A7E0-4FB6-B209-6CAF1CAA220AQ35034401-9DE5FABA-EEB9-48CF-86D4-76B2AC5AE785Q35043211-C31055D9-0CDE-40F4-80B9-D6FEBF62B863Q35079584-058BD6DA-213D-46A0-B93E-7F2876DE474CQ35087460-EA32EAF5-406F-4F4E-A70E-939CBAFDAB5EQ35112505-40C47718-42A4-4B75-8A7F-0BFDDB8CD8CFQ35328494-5100D46D-C068-47FB-A4E2-C453A6CF0851Q35985930-DDECE783-456F-4407-A8CB-F4CE37313DD4Q36220442-BB9ABC21-7223-46D3-BA72-9ECFF2E2ABF3Q36327895-BF795528-E639-47A2-A5DA-410B1551E522Q36545199-7A8620A9-B015-4671-8601-683FB7A1F6B1Q36627142-B36A1D52-14F7-4BE5-9B3D-F410A21DC1B2Q36749075-F392EF4F-4456-40C7-A158-2F809171C2F9Q36909371-A9B96CD2-4D06-4DB4-B5E7-01E77139BBE5Q37038867-C66C704C-CC3F-4277-8786-1137D741E197Q37051044-E7EFD512-D085-426D-90D9-D0EC7D26E96EQ37074209-CB1F2734-B142-43FD-B0C3-664FB433FA78Q37109605-A1CC0742-B7C1-4EDD-8AE1-3D4014359CA2Q37343824-61ECB0F7-CD10-457E-ADAA-079F8653FE9FQ37594794-81F1114C-974D-4B2F-913A-CA844FE27B1AQ37866549-38BEAC65-EFD3-41CA-BA20-FE7FD1BC698CQ37997470-0CAB99E7-8DD6-4D73-9C94-62EC08B506C0Q38262146-5B492FEE-5E8A-4518-8EBC-B344A3F15FA6Q38506539-240C1A25-5F98-4589-9FC1-D0FB3F16134FQ38693545-B8155517-202A-4AD6-BD01-A1DDB0B2D14DQ38834554-79C542EC-EE6C-48E8-9CE6-75BE82335012Q39151620-74E7D33E-05C3-4BB1-999A-758706C30ED8Q39952328-8805F61B-B1E2-444F-B267-198196754560
P2860
Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and S
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Bone marrow transplantation as ...... Hurler, Maroteaux-Lamy, and S
@ast
Bone marrow transplantation as ...... Hurler, Maroteaux-Lamy, and S
@en
type
label
Bone marrow transplantation as ...... Hurler, Maroteaux-Lamy, and S
@ast
Bone marrow transplantation as ...... Hurler, Maroteaux-Lamy, and S
@en
prefLabel
Bone marrow transplantation as ...... Hurler, Maroteaux-Lamy, and S
@ast
Bone marrow transplantation as ...... Hurler, Maroteaux-Lamy, and S
@en
P2093
P1476
Bone marrow transplantation as ...... Hurler, Maroteaux-Lamy, and S
@en
P2093
P304
P356
10.1097/00019052-199904000-00007
P577
1999-04-01T00:00:00Z